CB-Lin 0.25 Tablet
Prescription Required
Product introduction
CB-Lin 0.25 Tablet is a dopamine agonist. It is used for the treatment of a high level of prolactin. It is also helpful in stopping breast milk production in cases of stillbirth, abortion, or miscarriage.
is used to treat Parkinson's disease (a disorder of the nervous system that causes difficulties with movement and balance) and also has multiple other actions
Uses of CB-Lin Tablet
Benefits of CB-Lin Tablet
In Treatment of High levels of prolactin
Prolactin is a hormone that helps in the growth and development of breasts and also causes milk secretion in females. CB-Lin 0.25 Tablet helps stop breast milk secretion in females who have had a stillbirth, miscarriage, or abortion. It acts on a chemical in the brain, dopamine, that is responsible for these high levels of prolactin and stops milk secretion.
Side effects of CB-Lin Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of CB-Lin
- Nausea
- Constipation
- Dizziness
- Fatigue
- Headache
- Vomiting
- Vertigo
- Abdominal pain
- Breast pain
- Sleepiness
- Valvulopathy and related disorders
- Dyspepsia
- Gastritis
- Weakness
- Depression
- Postural hypotension (low blood pressure)
- Hot flushes
How to use CB-Lin Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. CB-Lin 0.25 Tablet is to be taken with food.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with CB-Lin 0.25 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
CB-Lin 0.25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
CB-Lin 0.25 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
CB-Lin 0.25 Tablet is usually not used during breastfeeding because it suppresses lactation.
CB-Lin 0.25 Tablet is usually not used during breastfeeding because it suppresses lactation.
Driving
UNSAFE
CB-Lin 0.25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
CB-Lin 0.25 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of CB-Lin 0.25 Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
CB-Lin 0.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of CB-Lin 0.25 Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
CB-Lin 0.25 Tablet
₹43.88/Tablet
Cabgolin 0.25 Tablet
Sun Pharmaceutical Industries Ltd
₹25.75/tablet
41% cheaper
Caberlin 0.25 Tablet
Sun Pharmaceutical Industries Ltd
₹23.63/tablet
46% cheaper
Camforte 0.25mg Tablet
Maneesh Pharmaceuticals Ltd
₹48.29/tablet
10% costlier
Cabliz 0.25mg Tablet
Macleods Pharmaceuticals Pvt Ltd
₹52.25/tablet
19% costlier
Caberlact 0.25mg Tablet
Neon Laboratories Ltd
₹36.25/tablet
17% cheaper
Quick tips
- CB-Lin 0.25 Tablet is used to treat conditions such as infertility or abnormal production of breast milk (galactorrhoea) caused due to excess production of a natural hormone called prolactin.
- To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
- Do not take CB-Lin 0.25 Tablet if you are breastfeeding.
- Take it with or after food to avoid side effects such as nausea or indigestion.
- Be cautious while driving or doing anything that requires concentration as CB-Lin 0.25 Tablet can cause dizziness and sleepiness.
- Regular monitoring of blood pressure may be advised during treatment with CB-Lin 0.25 Tablet.
Fact Box
Chemical Class
Ergolines
Habit Forming
No
Therapeutic Class
GYNAECOLOGICAL
Action Class
Dopamine agonists-Hyperprolactinemia
Patient concerns
User feedback
Patients taking CB-Lin 0.25 Tablet
Once A Week
42%
Twice A Week
35%
Once A Day
16%
Twice A Day
4%
Twice A Month
4%
What are you using CB-Lin Tablet for?
Increased pro*
86%
Acromegaly
14%
*Increased prolactin levels
How much was the improvement?
Average
44%
Poor
33%
Excellent
22%
What were the side-effects while using CB-Lin 0.25 Tablet?
Nausea
50%
Peripheral ed*
50%
*Peripheral edema
FAQs
What is CB-Lin 0.25 Tablet and what is it used for?
CB-Lin 0.25 Tablet contains Cabergoline, which belongs to a group of medicines that reduces the level of prolactin. It is used to treat medical problems such as galactorrhoea due to abnormally high level of prolactin. It is also used to stops breast milk production (lactation) in case of stillbirth, abortion or miscarriage.
How and in what dose should I take CB-Lin 0.25 Tablet?
Take this medicine, as per the advice of your doctor. The advised dose and duration depend on your medical condition. It is recommended to take this medicine with food or after food, to reduce the chances of nausea or vomiting.
What are the possible side effects of using CB-Lin 0.25 Tablet?
During the first few days of treatment, this medicine may decrease your blood pressure which could make you feel dizzy. So, it is recommended that you change your position slowly when trying to sit, stand or lie down during the initial days of the treatment. Your doctor may suggest you to monitor your blood pressure regularly during these days. The other common side effects are drowsiness, nausea, headache, dizziness, vertigo, stomach pain, indigestion, fatigue, and weakness. If any of these side effects bother you, consult your doctor.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Parker KL, Schimmer BP. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1114-15.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 176-709.
- Mayo Clinic. Cabergoline. [Accessed 03 Apr. 2019] (online) Available from:
- Cabergoline. Sandwich, Kent: Pfizer Limited; 1996 [revised May 2018].[Accessed 22 Jan. 2019] (online) Available from:
- Cabergoiline. New York, New York: Pfizer; 2014. [Accessed 03 Apr. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from:
- Cabergoline [Prescribing Information]. Libertyville, IL: A-S Medication Solutions; 2023. [Accessed 12 Jun, 2023] (online) Available from:
Marketer details
Name: Serum Institute Of India Ltd
Address: 212/2, Hadapsar, Off Soli Poonawalla Road, Pune 411028 India
Country of origin: India
Lab tests offered by us
Related/Popular tests
52 people bought this recentlyMRP
₹87.75
Inclusive of all taxes
2.0 tablets in 1 strip
SOLD OUT